Replimune Group, Inc. — Director's Dealing 2021

Apr 6, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2021-04-01

Reporting Person: Lewis Tanya (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-01	Stock Option (right to buy)	$31.58	A	16500	Acquired	2031-04-01	Common Stock (16500)	Direct

Footnotes

F1: The shares underlying this option vest entirely on April 1, 2022.